- Home
- IPHA vs CRNT Comparison
IPHA vs CRNT Comparison
Compare IPHA & CRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPHA | CRNT |
|---|---|---|
| Founded | 1999 | 1996 |
| Country | France | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.2M | 182.5M |
| IPO Year | 2019 | 2000 |
Fundamental Metrics
Financial Performance| Metric | IPHA | CRNT |
|---|---|---|
| Price | $1.71 | $2.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $5.00 | $4.00 |
| AVG Volume (30 Days) | 26.6K | ★ 494.8K |
| Earning Date | 09-17-2025 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | $14,839,695.00 | ★ $363,330,000.00 |
| Revenue This Year | $22.29 | N/A |
| Revenue Next Year | $43.90 | $5.06 |
| P/E Ratio | ★ N/A | $134.91 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.60 | $1.82 |
| 52 Week High | $2.63 | $5.73 |
Technical Indicators
Market Signals| Indicator | IPHA | CRNT |
|---|---|---|
| Relative Strength Index (RSI) | 36.12 | 51.49 |
| Support Level | $1.64 | $2.04 |
| Resistance Level | $1.81 | $2.13 |
| Average True Range (ATR) | 0.08 | 0.09 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 18.75 | 76.19 |
Price Performance
Historical ComparisonAbout IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.